Isomaltose

Isomaltose is a disaccharide consisting of two glucose molecules joined by an alpha(1-6) glycosidic bond, primarily arising from the enzymatic breakdown of starch components like amylopectin (PubChem CID 439193). In the human digestive system, it serves as a critical substrate for the brush-border enzyme sucrase-isomaltase, which hydrolyzes it into glucose for absorption into the bloodstream (UniProt P14410). While isomaltose itself is a metabolic intermediate rather than a traditional protein target, its processing is central to several clinical conditions. For instance, Congenital Sucrase-Isomaltase Deficiency (CSID) is a genetic disorder where the lack of functional enzyme leads to the malabsorption of isomaltose, causing severe gastrointestinal distress (NIH/NIDDK). Pharmacological intervention often involves enzyme replacement therapy with sacrosidase to provide the necessary digestive activity (FDA). Alternatively, alpha-glucosidase inhibitors like acarbose and miglitol are used to modulate the rate of carbohydrate digestion, including isomaltose hydrolysis, to manage blood glucose levels in diabetic patients (StatPearls). Therefore, while not a receptor or enzyme itself, isomaltose is a key molecule in the study of metabolic disorders and carbohydrate pharmacology. Monitoring its malabsorption through breath hydrogen tests or fecal acidity serves as a diagnostic tool for intestinal enzyme deficiencies.

Other names

6-O-alpha-D-Glucopyranosyl-D-glucoseIsomaltobiose

Isomaltose acts as a substrate for the enzyme sucrase-isomaltase; drugs like sacrosidase act as enzyme replacements to facilitate its digestion, while alpha-glucosidase inhibitors like acarbose and miglitol competitively inhibit the enzyme to delay its hydrolysis and slow glucose absorption (StatPearls, FDA).